Orel V. E, Mitrelias T, Tselepi M, Nikolov N. A, Rykhalskiy A. Y, Dzyatkovskya N. N, Romanov A. V, C. H. W. Barnes, Orel I. V and Schepotin I. B
Accepted Abstracts: J Cancer Sci Ther
T his lecture will address principally the cellular and molecular immunopathological-aspects of glyoma; and the experimental approaches for establishing the appropriate bench model to develop the immunotherapeutics as a personalized medicine. In addition to these subjects, attendees of this lecture will be familiarized with the need for testing the efficacy of immunotherapeutics, for an individual glyoma can be applied when treating brain tumor patients. Such approach might be applied for other Cancer such as bladder cancer, melanoma. The experimental techniques such as organo-typic (spheroid) and histio-typic monolayer glyoma cell cultures and the identification molecular markers for improved diagnosis will be discussed.
Pranab K. Das has mainly studied inflammation and immunity. In parallel, he studied tumor molecular biology including brain tumour and development of therapeutics. During the progression of his career covering cancer, infection / immunity, gene expression, he authored more than 200 scientific articles published in peer reviewed journals. He has served on numerous review committees for the European research programmes.